A chemical proteomics approach to identify c-di-GMP binding proteins in Pseudomonas aeruginosa

Journal of Microbiological Methods

Volumn 88, Issue 2, 2012, Pages 229-236

  Düvel, Juliane ^a   Bertinetti, Daniela ^b   Möller, Stefan ^b   Schwede, Frank ^c   Morr, Michael ^a   Wissing, Josef ^a   Radamm, Lena ^a,f   Zimmermann, Bastian ^d   Genieser, Hans Gottfried ^c   Jänsch, Lothar ^a   Herberg, Friedrich W ^b   Häussler, Susanne ^a,e  

^a HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

^b UNIVERSITY OF KASSEL   (Germany)

^c BIOLOG Life Science Institute   (Germany)

^d Biaffin GmbH and CoKG   (Germany)

^e INSTITUTE OF INFECTION IMMUNOLOGY   (Germany)

^f UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

C di GMP affinity pull down; Chemical proteomics; Surface plasmon resonance

Indexed keywords

2' AMINOHEXYLCARBAMOYL CYCLIC DI GMP; CYCLIC GMP DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; BIOCHEMISTRY; CONTROLLED STUDY; ENZYME ANALYSIS; ENZYME IMMOBILIZATION; ENZYME SYNTHESIS; IN VITRO STUDY; MASS SPECTROMETRY; MOLECULAR INTERACTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN TARGETING; PROTEOMICS; PSEUDOMONAS AERUGINOSA; SIGNAL TRANSDUCTION; SURFACE PLASMON RESONANCE;

BACTERIAL PROTEINS; CARRIER PROTEINS; CYCLIC GMP; PROTEOMICS; PSEUDOMONAS AERUGINOSA; SIGNAL TRANSDUCTION; SURFACE PLASMON RESONANCE;

PSEUDOMONAS AERUGINOSA;

EID: 84856405959     PISSN: 01677012     EISSN: 18728359     Source Type: Journal    
DOI: 10.1016/j.mimet.2011.11.015     Document Type: Article

References (43)

1. Benach J., Swaminathan S.S., Tamayo R., Handelman S.K., Folta-Stogniew E., Ramos J.E., Forouhar F., Neely H., Seetharaman J., Camilli A., Hunt J.F. The structural basis of cyclic diguanylate signal transduction by PilZ domains. EMBO J. 2007, 26:5153-5166.
2. Bertinetti D., Schweinsberg S., Hanke S.E., Schwede F., Bertinetti O., Drewianka S., Genieser H., Herberg F.W. Chemical tools selectively target components of the PKA system. BMC Chem. Biol. 2009, 9:3.
3. Chan C., Paul R., Samoray D., Amiot N.C., Giese B., Jenal U., Schirmer T. Structural basis of activity and allosteric control of diguanylate cyclase. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:17084-17089.
4. Christen M., Christen B., Folcher M., Schauerte A., Jenal U. Identification and characterization of a cyclic di-GMP-specific phosphodiesterase and its allosteric control by GTP. J. Biol. Chem. 2005, 280:30829-30837.
5. Christen B., Christen M., Paul R., Schmid F., Folcher M., Jenoe P., Meuwly M., Jenal U. Allosteric control of cyclic di-GMP signaling. J. Biol. Chem. 2006, 281:32015-32024.
6. De N., Pirruccello M., Krasteva P.V., Bae N., Raghavan R.V., Sondermann H. Phosphorylation-independent regulation of the diguanylate cyclase WspR. PLoS Biol. 2008, 6:e67.
7. Galperin M.Y., Nikolskaya A.N., Koonin E.V. Novel domains of the prokaryotic two-component signal transduction systems. FEMS Microbiol. Lett. 2001, 203:11-21.
8. Hanke S.E., Bertinetti D., Badel A., Schweinsberg S., Genieser H., Herberg F.W. Cyclic nucleotides as affinity tools: phosphorothioate cAMP analogues address specific PKA subproteomes. N. Biotechnol. 2011, 28:294-301.
9. Hayakawa Y., Nagata R., Hirata A., Hyodo M., Kawai R. A facile synthesis of cyclic bis(3'-5')diguanylic acid. Tetrahedron 2003, 59:6465-6471.
10. Hengge R. Principles of c-di-GMP signalling in bacteria. Nat. Rev. Microbiol. 2009, 7:263-273.
11. Hickman J.W., Harwood C.S. Identification of FleQ from Pseudomonas aeruginosa as a c-di-GMP-responsive transcription factor. Mol. Microbiol. 2008, 69:376-389.
12. Hickman J.W., Tifrea D.F., Harwood C.S. A chemosensory system that regulates biofilm formation through modulation of cyclic diguanylate levels. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:14422-14427.
13. Jenal U., Malone J. Mechanisms of cyclic-di-GMP signaling in bacteria. Annu. Rev. Genet. 2006, 40:385-407.
14. Keller A., Nesvizhskii A.I., Kolker E., Aebersold R. Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search. Anal. Chem. 2002, 74:5383-5392.
15. Ko J., Ryu K., Kim H., Shin J., Lee J., Cheong C., Choi B. Structure of PP4397 reveals the molecular basis for different c-di-GMP binding modes by Pilz domain proteins. J. Mol. Biol. 2010, 398:97-110.
16. Krasteva P.V., Fong J.C.N., Shikuma N.J., Beyhan S., Navarro M.V.A.S., Yildiz F.H., Sondermann H. Vibrio cholerae VpsT regulates matrix production and motility by directly sensing cyclic di-GMP. Science 2010, 327:866-868.
17. Kulasakara H., Lee V., Brencic A., Liberati N., Urbach J., Miyata S., Lee D.G., Neely A.N., Hyodo M., Hayakawa Y., Ausubel F.M., Lory S. Analysis of Pseudomonas aeruginosa diguanylate cyclases and phosphodiesterases reveals a role for bis-(3'-5')-cyclic-GMP in virulence. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:2839-2844.
18. Leduc J.L., Roberts G.P. Cyclic di-GMP allosterically inhibits the CRP-like protein (Clp) of Xanthomonas axonopodis pv. citri. J. Bacteriol. 2009, 191:7121-7122.
19. Lee V.T., Matewish J.M., Kessler J.L., Hyodo M., Hayakawa Y., Lory S. A cyclic-di-GMP receptor required for bacterial exopolysaccharide production. Mol. Microbiol. 2007, 65:1474-1484.
20. Lee E.R., Baker J.L., Weinberg Z., Sudarsan N., Breaker R.R. An allosteric self-splicing ribozyme triggered by a bacterial second messenger. Science 2010, 329:845-848.
21. Lewenza S., Falsafi R.K., Winsor G., Gooderham W.J., McPhee J.B., Brinkman F.S.L., Hancock R.E.W. Construction of a mini-Tn5-luxCDABE mutant library in Pseudomonas aeruginosa PAO1: a tool for identifying differentially regulated genes. Genome Res. 2005, 15:583-589.
22. Merighi M., Lee V.T., Hyodo M., Hayakawa Y., Lory S. The second messenger bis-(3'-5')-cyclic-GMP and its PilZ domain-containing receptor Alg44 are required for alginate biosynthesis in Pseudomonas aeruginosa. Mol. Microbiol. 2007, 65:876-895.
23. Moll D., Prinz A., Gesellchen F., Drewianka S., Zimmermann B., Herberg F.W. Biomolecular interaction analysis in functional proteomics. J. Neural Transm. 2006, 113:1015-1032.
24. Navarro M.V.A.S., De N., Bae N., Wang Q., Sondermann H. Structural analysis of the GGDEF-EAL domain-containing c-di-GMP receptor FimX. Structure 2009, 17:1104-1116.
25. Nesvizhskii A.I., Keller A., Kolker E., Aebersold R. A statistical model for identifying proteins by tandem mass spectrometry. Anal. Chem. 2003, 75:4646-4658.
26. Paul R., Weiser S., Amiot N.C., Chan C., Schirmer T., Giese B., Jenal U. Cell cycle-dependent dynamic localization of a bacterial response regulator with a novel di-guanylate cyclase output domain. Genes Dev. 2004, 18:715-727.
27. Rix U., Superti-Furga G. Target profiling of small molecules by chemical proteomics. Nat. Chem. Biol. 2009, 5:616-624.
28. Römling U., Amikam D. Cyclic di-GMP as a second messenger. Curr. Opin. Microbiol. 2006, 9:218-228.
29. Ryan R.P., Fouhy Y., Lucey J.F., Crossman L.C., Spiro S., He Y., Zhang L., Heeb S., Cámara M., Williams P., Dow J.M. Cell-cell signaling in Xanthomonas campestris involves an HD-GYP domain protein that functions in cyclic di-GMP turnover. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:6712-6717.
30. Ryjenkov D.A., Tarutina M., Moskvin O.V., Gomelsky M. Cyclic diguanylate is a ubiquitous signaling molecule in bacteria: insights into biochemistry of the GGDEF protein domain. J. Bacteriol. 2005, 187:1792-1798.
31. Schirmer T., Jenal U. Structural and mechanistic determinants of c-di-GMP signalling. Nat. Rev. Microbiol. 2009, 7:724-735.
32. Schmidt A.J., Ryjenkov D.A., Gomelsky M. The ubiquitous protein domain EAL is a cyclic diguanylate-specific phosphodiesterase: enzymatically active and inactive EAL domains. J. Bacteriol. 2005, 187:4774-4781.
33. Schmidt J., Müsken M., Becker T., Magnowska Z., Bertinetti D., Möller S., Zimmermann B., Herberg F.W., Jänsch L., Häussler S. The Pseudomonas aeruginosa chemotaxis methyltransferase CheR1 impacts on bacterial surface sampling. PLoS One 2011, 6:e18184.
34. Scholten A., Poh M.K., van Veen T.A.B., van Breukelen B., Vos M.A., Heck A.J.R. Analysis of the cGMP/cAMP interactome using a chemical proteomics approach in mammalian heart tissue validates sphingosine kinase type 1-interacting protein as a genuine and highly abundant AKAP. J. Proteome Res. 2006, 5:1435-1447.
35. Seshasayee A.S.N., Fraser G.M., Luscombe N.M. Comparative genomics of cyclic-di-GMP signalling in bacteria: post-translational regulation and catalytic activity. Nucleic Acids Res. 2010, 38:5970-5981.
36. Simm R., Morr M., Kader A., Nimtz M., Römling U. GGDEF and EAL domains inversely regulate cyclic di-GMP levels and transition from sessility to motility. Mol. Microbiol. 2004, 53:1123-1134.
37. Stenberg E., Persson B., Roos H., Urbaniczky C. Quantitative determination of surface concentration of protein with surface plasmon resonance using radiolabeled proteins. J. Colloid Interface Sci. 1991, 143(2):513-526.
38. Sudarsan N., Lee E.R., Weinberg Z., Moy R.H., Kim J.N., Link K.H., Breaker R.R. Riboswitches in eubacteria sense the second messenger cyclic di-GMP. Science 2008, 321:411-413.
39. Tal R., Wong H.C., Calhoon R., Gelfand D., Fear A.L., Volman G., Mayer R., Ross P., Amikam D., Weinhouse H., Cohen A., Sapir S., Ohana P., Benziman M. Three cdg operons control cellular turnover of cyclic di-GMP in Acetobacter xylinum: genetic organization and occurrence of conserved domains in isoenzymes. J. Bacteriol. 1998, 180:4416-4425.
40. Wassmann P., Chan C., Paul R., Beck A., Heerklotz H., Jenal U., Schirmer T. Structure of BeF3- -modified response regulator PleD: implications for diguanylate cyclase activation, catalysis, and feedback inhibition. Structure 2007, 15:915-927.
41. Wessel D., Flügge U.I. A method for the quantitative recovery of protein in dilute solution in the presence of detergents and lipids. Anal. Biochem. 1984, 138:141-143.
42. Winsor G.L., Lo R., Sui S.J.H., Ung K.S.E., Huang S., Cheng D., Ching W.H., Hancock R.E.W., Brinkman F.S.L. Pseudomonas aeruginosa Genome Database and PseudoCAP: facilitating community-based, continually updated, genome annotation. Nucleic Acids Res. 2005, 33:D338-D343.
43. Zimmermann B., Hahnefeld C., Herberg F.W. Applications of biomolecular interaction analysis in drug development. TARGETS 2002, 1:66-73.